CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India
Ashish Agarwal, Saurabh Kedia, Saransh Jain, Vipin Gupta, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Venigalla Pratap Mouli, Rajan Dhingra, Govind Makharia, Vineet Ahuja
Intest Res. 2018;16(4):588-598.   Published online October 10, 2018
DOI: https://doi.org/10.5217/ir.2018.00023

Excel Download

High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India
Intestinal Research. 2018;16(4):588-598   Crossref logo
Link1 Link2 Link3

Sa1717 - Very High Rate of Tuberculosis Complicating Infliximab Therapy for Inflammatory Bowel Disease Despite Tuberculosis Screening in India
Gastroenterology. 2018;154(6):S-367   Crossref logo
Link1 Link2

Multidrug resistant miliary tuberculosis during infliximab therapy despite tuberculosis screening
Australasian Journal of Dermatology. 2013;55(2):140-141   Crossref logo
Link1

Su1150 – Risk of Tuberculosis in Patients with Inflammatory Bowel Disease on Infliximab Or Adalimumab is Dependent on the Local Disease Burden of Tuberculosis: A Systematic Review and Meta-Analysis
Gastroenterology. 2019;156(6):S-516-S-517   Crossref logo
Link1 Link2

Asymptomatic hyperCKemia During Infliximab Therapy in Patients With Inflammatory Bowel Disease
Inflammatory Bowel Diseases. 2018;24(6):1272-1273   Crossref logo
Link1

Asymptomatic hyperCKemia During Infliximab Therapy in Patients With Inflammatory Bowel Disease
Inflammatory Bowel Diseases. 2018;24(6):1266-1271   Crossref logo
Link1

Infliximab-induced tuberculosis in patients with UC: Experience from India-a country with high prevalence of tuberculosis
Journal of Gastroenterology and Hepatology. 2017;32(6):1191-1194   Crossref logo
Link1 Link2 Link3

Su1854 – Profile of Patients with Inflammatory Bowel Disease Who Developed Active Tuberculosis Despite Negative Screening Prior to the Introduction of Anti-TNF Therapy
Gastroenterology. 2019;156(6):S-636   Crossref logo
Link1 Link2

Methotrexate/infliximab
Reactions Weekly. 2017;1643(1):197-197   Crossref logo
Link1 Link2 Link3

755. Clinical Adherence to Latent Tuberculosis Screening Recommendations in Adults with Inflammatory Bowel Disease (IBD) Prior to Biologic Therapy
Open Forum Infectious Diseases. 2018;5(suppl_1):S271-S271   Crossref logo
Link1